|
|
|
|
||
Re: Presentation Slides<Were not all those in the highest dose cohort among the 'six responders'?> We do not have that information. What slide 28 shows is the distribution of blood concentration of Anavex 2-73 versus increases in ADCS-ADL scores over 57 weeks (not 109 weeks). The graph shows that patients 1007, 1013, 1014, 2001, 2006, and 2010 had high concentrations and improved scores. Patients 1003, 1015, and 3001 had medium concentrations of 2-73 and also scored well. But one patient, 1011, had low concentration and scored well. The graph on the following page shows six patients at 109 weeks. Only four of those are the same as the ones I just listed as having high concentration in the blood. You can do the same exercise with slide 27. |
return to message board, top of board |